Related Experiment Video
Updated: Mar 8, 2026

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate
Published on: June 25, 2019
A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion
Makoto Shigeto1,2, Chae Young Cha3, Patrik Rorsman3
1Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Oxford, OX3 7LE, UK. shigeto@med.kawasaki-m.ac.jp.
Abstract:
Glucagon-like peptide-1 (GLP-1) is an endogenous glucose-lowering hormone and GLP-1 receptor agonists are currently being used as antidiabetic drugs clinically. The canonical signalling pathway (including cAMP, Epac2, protein kinase A (PKA) and KATP channels) is almost universally accepted as the main mechanism of GLP-1-stimulated insulin secretion. This belief is based on in vitro studies that used nanomolar (1-100 nM) concentrations of GLP-1. Recently, it was found that the physiological concentrations (1-10 pM) of GLP-1 also stimulate insulin secretion from isolated islets, induce membrane depolarization and increase of intracellular [Ca2+] in isolated β cells/pancreatic islets. These responses were unaffected by PKA inhibitors and occurred without detectable increases in intracellular cAMP and PKA activity. These PKA-independent actions of GLP-1 depend on protein kinase C (PKC), involve activation of the standard GLP-1 receptor (GLP1R) and culminate in activation of phospholipase C (PLC), leading to an elevation of diacylglycerol (DAG), increased L-type Ca2+ and TRPM4/TRPM5 channel activities. Here, we review these recent data and contrast them against the effects of nanomolar concentrations of GLP-1. The differential intracellular signalling activated by low and high concentrations of GLP-1 could provide a clue to explain how GLP-1 exerts different function in the central nervous system and peripheral organs.
Insights
Glucagon-like peptide-1 (GLP-1) at physiological concentrations stimulates insulin secretion via a novel protein kinase C (PKC) pathway, distinct from the established protein kinase A (PKA) pathway. This discovery offers insights into GLP-1
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Signaling
Background:
- Glucagon-like peptide-1 (GLP-1) is an endogenous hormone crucial for glucose regulation.
- GLP-1 receptor agonists are established antidiabetic therapies.
- The canonical cAMP-Epac2-PKA-KATP channel pathway is widely accepted for GLP-1-stimulated insulin secretion, based on high-concentration studies.
Purpose of the Study:
- To review and contrast the signaling mechanisms of GLP-1 at physiological (pM) versus pharmacological (nM) concentrations.
- To highlight the recently discovered PKA-independent pathway activated by physiological GLP-1 levels.
- To explore how differential signaling might explain diverse GLP-1 functions.
Main Methods:
- Review of recent in vitro studies on isolated islets and beta cells.
- Analysis of GLP-1 effects at nanomolar (1-100 nM) and picomolar (1-10 pM) concentrations.
- Investigation of signaling components including cAMP, PKA, PKC, PLC, Ca2+ channels, and KATP channels.
Main Results:
- Physiological GLP-1 concentrations stimulate insulin secretion, depolarization, and Ca2+ influx independently of PKA and cAMP.
- These low-concentration effects are mediated by PKC, GLP1R, PLC, and involve DAG elevation and altered Ca2+ and TRPM channel activity.
- Pharmacological GLP-1 concentrations activate the canonical cAMP-PKA pathway.
Conclusions:
- GLP-1 utilizes distinct intracellular signaling pathways at physiological and pharmacological concentrations.
- The PKA-independent pathway activated by physiological GLP-1 is crucial for insulin secretion.
- Understanding these differential pathways may elucidate GLP-1's diverse roles in the central nervous system and periphery.
More Related Videos
07:00Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine
Published on: February 26, 2019
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Insulin: The Receptor and Signaling Pathways
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin Secretory Vesicles
GPCRs Regulate Adenylyl Cylase Activity